Clinical Trial Update: COVID-19 and Anti-CD14 Treatment Trial [Phase 2]

View source ↗

Summary

Phase 2 trial of anti-CD14 treatment for COVID-19/SARS-CoV-2 has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019
• Respiratory Syndrome Coronavirus 2

Drugs mentioned

• anti-CD14 treatment

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Coronavirus Disease 2019 (COVID-19), Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Phase 2 | Status: TERMINATED | Results posted: 2023-06-15